Bleeding complications associated with percutaneous renal biopsy using Biopince® needle

Daram, Sumanth; Reddivari, Venkata; Bastani, Bahar

doi:10.1007/s11255-010-9773-0

Cited by 3 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This indicated that ultrasonographic evaluation of hematoma size immediately after renal biopsy was useful in predicting potentially severe blood loss. A conclusion was also made in the study by Daram et al [8] that the degree of decline in Hct at 6 h was predictive of the degree of decline at 18–24 h. But this result still needs to be validated in larger prospective studies.…”

Section: Measures That Related To Minimizing the Bleeding Complicationsmentioning

confidence: 91%

“…Also, the meta-analysis by Corapi et al [7] summaries that the complication rate of macroscopic hematuria is 3.5 % (95 % CI 2.2–5.1 %), and erythrocyte transfusion is 0.9 % (95 % CI 0.4–1.5 %). Besides, in the studies by Daram et al [8], around a quarter of patients had >10 % decline in hematocrit at 24 h, requiring blood transfusion in 3.6–9 % of the patients and an incidence of gross hematuria of 3.6–17 %. A large series of >9,000 biopsies in pediatric and adult patients is recently reported by Tondel et al [9], and their study shows that gross hematuria appears after biopsy in 1.9 % of the patients and 0.9 % of patients need blood transfusion.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Factors that can minimize bleeding complications after renal biopsy

Zhu

Chen

2014

Int Urol Nephrol

View full text Add to dashboard Cite

Renal biopsy is a very important diagnostic tool in the evaluation of renal diseases. However, bleeding remains to be one of the most serious complications in this procedure. Many new techniques have been improved to make it safer. The risk factors and predictors of bleeding after percutaneous renal biopsy have been extensively reported in many literatures, and generally speaking, the common risk factors for renal biopsy complications focus on hypertension, high serum creatinine, bleeding diatheses, amyloidosis, advanced age, gender and so on. Our primary purpose of this review is to summarize current measures in recent years literature aiming at minimizing the bleeding complication after the renal biopsy, including the drug application before and after renal biopsy, operation details in percutaneous renal biopsies, nursing and close monitoring after the biopsy and other kinds of biopsy methods.

show abstract

Section: Measures That Related To Minimizing the Bleeding Complicationsmentioning

confidence: 91%

Section: Introductionmentioning

confidence: 99%

Factors that can minimize bleeding complications after renal biopsy

Zhu

Chen

2014

Int Urol Nephrol

View full text Add to dashboard Cite

show abstract

“…Corapi et al [9] carried out a study which encompasses the complication rate of macroscopic hematuria is 3.5%. In addition, in the study of Daram et al [10] , it is explained that requiring blood transfusion in 3.6-9% of the patients and an incidence of gross hematuria of 3.6-17%.…”

Section: Discussionmentioning

confidence: 99%

Renal Biopsy Technique and Complications

Turan¹,

Erol²

2016

Journal of Nephrology Research

View full text Add to dashboard Cite

Renal biopsy is notably used for diagnosis and therapy guidance of renal diseases. Percutaneous renal biopsy has crucially improved safety-wise after the routine use of spring-loaded needles and the use of real-time ultrasound guidance. Renal biopsy includes potential complications such as bleeding, infection, pain and loss of kidney. As percutaneous approach is contraindicated, laparoscopic or transjugular renal biopsy can be used as an alternative.

show abstract

“…• A hematoma is present but <2cm [84] and no hematocrit changes occur within the first 6 hrs [110,111].…”

Section: Bleeding Risk Modification and Risk Reduction Techniquesmentioning

confidence: 99%

Comments and extensions to EFSUMB guidelines on renal interventional ultrasound (INVUS).

et al. 2016

View full text Add to dashboard Cite

A substantial evidence base for interventional ultrasound approaches to renal diagnostic sampling and therapeutic access exists. This review comments on the evidence-based recommendations regarding ultrasound-guided renal access which have been published recently within the framework of Guidelines on Interventional Ultrasound (InVUS) of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) from a clinical practice point of view. Specific aspects of tissue handling and workup, procedural approach and patient interaction are discussed. Indications, contraindications, risk factors and methods to reduce these risks are considered.

show abstract

Bleeding complications associated with percutaneous renal biopsy using Biopince® needle

Cited by 3 publications

References 4 publications

Factors that can minimize bleeding complications after renal biopsy

Factors that can minimize bleeding complications after renal biopsy

Renal Biopsy Technique and Complications

Comments and extensions to EFSUMB guidelines on renal interventional ultrasound (INVUS).

Contact Info

Product

Resources

About